Centessa Pharmaceuticals (CNTA) Research & Development (2022 - 2025)
Historic Research & Development for Centessa Pharmaceuticals (CNTA) over the last 4 years, with Q3 2025 value amounting to $41.6 million.
- Centessa Pharmaceuticals' Research & Development rose 2259.39% to $41.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $178.6 million, marking a year-over-year increase of 4999.33%. This contributed to the annual value of $150.2 million for FY2024, which is 2077.01% up from last year.
- Centessa Pharmaceuticals' Research & Development amounted to $41.6 million in Q3 2025, which was up 2259.39% from $42.7 million recorded in Q2 2025.
- Centessa Pharmaceuticals' 5-year Research & Development high stood at $60.9 million for Q4 2024, and its period low was $22.7 million during Q1 2024.
- Moreover, its 4-year median value for Research & Development was $33.7 million (2023), whereas its average is $36.5 million.
- Per our database at Business Quant, Centessa Pharmaceuticals' Research & Development plummeted by 3723.7% in 2023 and then skyrocketed by 10485.26% in 2024.
- Quarter analysis of 4 years shows Centessa Pharmaceuticals' Research & Development stood at $27.8 million in 2022, then rose by 6.76% to $29.7 million in 2023, then surged by 104.85% to $60.9 million in 2024, then tumbled by 31.72% to $41.6 million in 2025.
- Its Research & Development stands at $41.6 million for Q3 2025, versus $42.7 million for Q2 2025 and $33.4 million for Q1 2025.